Developer docs
API playgroundTry for free, no card

Search company profiles

Tracey Technologies

Full company profile

uuid000avhy

Namestring
Tracey Technologies
Legal namestring
Tracey Technologies Corporation
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Tracey Technologies is a privately held US medical device company founded in 1999 and headquartered in Houston, Texas, that designs, manufactures, and sells the iTrace — a 5-in-1 ophthalmic diagnostic workstation combining wavefront aberrometry, corneal topography, autorefraction, keratometry, and pupillometry in a single device. Its core technical differentiator is a patented ray tracing wavefront sensor that projects 256 parallel light rays through the pupil entrance and measures each ray's retinal landing position, enabling the device to mathematically separate corneal from internal optical contributions to vision loss — a capability the company states competitors using Hartmann-Shack sensors cannot replicate, particularly in highly aberrated eyes or through implanted/ocular-surface-compromised lenses. Layered on this sensor are proprietary 0–10 clinical indices (Dysfunctional Lens Index, Corneal Performance Index, Quality of Vision Index, Tear Film Index) plus surgical planning modules (Toric Planner, Toric Check) that the company markets primarily to cataract and refractive surgeons for premium IOL selection, toric IOL alignment, and post-operative verification.

The company monetizes primarily through one-time hardware sales of the iTrace device on a quote-based motion, supplemented by downloadable paid software upgrades (most recently iTrace Prime v7.0 in 2023), on-site and remote training, and ongoing customer support. It serves a global installed base of ophthalmologists and optometrists across the United States, Europe, Canada, Latin America, India, the Middle East, Russia, and Southern Africa, sold through a wholly direct sales organization of regional managers rather than a distributor network. The company is founder-controlled (CEO Joe Wakil, who also founded EyeSys Technologies, the firm credited with pioneering commercial corneal topography) and has not disclosed institutional funding, M&A, or leadership transitions.

Short descriptiontext

Tracey Technologies is a privately held Houston-based medical device company that designs and sells the iTrace, a 5-in-1 ophthalmic diagnostic workstation using patented ray tracing technology, primarily serving cataract and refractive surgeons globally via direct sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic diagnostic equipment, wavefront aberrometry devices, corneal topography systems, cataract surgery planning, ray tracing technology
Industry3 codes
PRIMARYHLAHAJAA
Refractive Diagnostics & Biometry (Autorefractors, Keratometers, Topography/Tomography, A-Scan/Optical Biometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAHAJAH
Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAKAKAF
Cornea, External Disease & Refractive Surgery (LASIK/PRK)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Ophthalmic Goods Manufacturing339115
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Ophthalmic Diagnostic Equipment
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1iTrace Device Sales
TypeHardware Sales
Description

Primary revenue from sale of the iTrace ophthalmic diagnostic device. The device combines wavefront aberrometry, corneal topography, autorefraction, keratometry, and pupillometry in a single piece of equipment for ophthalmic practices.

traceytechnologies.com
2Software Upgrades
TypeSubscription Recurring
Description

Revenue from software upgrades (e.g., Version 7.0 iTrace Prime) that can be downloaded on existing hardware, providing new features and capabilities.

traceytechnologies.com
3Customer Support & Training
TypeProfessional Services
Description

Ongoing support services including on-site and remote training, software activation, and technical support for existing iTrace users.

traceytechnologies.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1iTrace Device - Base Configuration
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Medical diagnostic device sold with base software. Pricing not publicly disclosed; requires direct inquiry.

traceytechnologies.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1iTrace
Description

The flagship 5-in-1 ophthalmic device combining wavefront aberrometry, corneal topography, autorefraction, keratometry, and pupillometry using proprietary ray-tracing technology.

traceytechnologies.com
+1 more record
Core offering1 text field

Tracey Technologies manufactures and sells the iTrace, a 5-in-1 ophthalmic diagnostic device that combines a wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer in a single unit. The device uses patented ray tracing technology (256 parallel light rays projected through the pupil) to objectively separate corneal from internal optical performance, and is sold with proprietary software (currently iTrace Prime / Version 7.0) that delivers diagnostic indices (DLI, CPI, QVI, TFI) and Toric Planner/Check surgical planning tools. The product is sold directly to ophthalmologists, cataract and refractive surgeons, and optometrists worldwide, supported by downloadable software upgrades and on-site or remote training.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 40% premium IOL conversion rate achieved by Dr. Garg (up from 5% prior to iTrace adoption)
+4 more records
Product overview1 text field

Tracey Technologies offers the iTrace as its core product — a unified ophthalmic diagnostic platform that combines 5 devices in 1 (wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer). The hardware platform is upgraded through software versions, with iTrace Prime (Version 7.0) being the latest. Key proprietary metrics include the Dysfunctional Lens Index (DLI), Corneal Performance Index (CPI), Quality of Vision Index (QVI), and Tear Film Index (TFI), all displayed on 0-10 scales for clinical decision-making. Surgical planning features include Toric Planner for pre-operative calculations and Toric Check for post-operative verification without dilation. The system enables separation of corneal from internal optical performance, making it unique for premium IOL selection and cataract surgery planning.

Product and service2 records
1iTrace Device
CategoryOphthalmic diagnostic hardware
Description

5-in-1 ophthalmic diagnostic device combining wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer in a single unit. Uses patented ray tracing technology to send 256 parallel light rays through the eye for objective measurement, sold to ophthalmologists, cataract and refractive surgeons, and optometrists.

2iTrace Prime Software (Version 7.0)
CategoryOphthalmic diagnostic software
Description

Latest software platform for the iTrace device featuring the Prime Dashboard, Tear Film Index, improved imaging quality, and enhanced surgical planning tools. Sold as a downloadable upgrade that adds new capabilities to existing iTrace hardware.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Topcon offers a broad portfolio of ophthalmic diagnostic instruments (refraction, OCT, corneal mapping, perimetry) used in optometry and ophthalmology practices worldwide. Topcon's multi-modality diagnostic platforms compete with iTrace for clinical budget and workflow integration, particularly in optometric referral practices.

TypeDirect peer
Description

OCULUS Pentacam is a leading corneal topography and tomography platform competing for the same diagnostic cabinet in refractive and cataract practices. Tracey markets directly against Pentacam on its website, indicating they compete for the same budget, same workflow, and same surgical planning use cases — particularly cataract/IOL and refractive surgery pre-operative assessment.

TypeBroad incumbent
Description

Alcon is a global leader in cataract surgical devices and premium IOLs (PanOptix, Vivity) following its acquisition of WaveLight and other diagnostic assets. As a buyer of premium IOLs, Alcon's equipment partners and bundled diagnostic solutions compete with the iTrace in the same ophthalmic surgical suite.

TypeEmerging player
Description

CSO is an Italian ophthalmic equipment manufacturer specializing in corneal topography, aberrometry, and biometry devices sold to ophthalmic clinics worldwide. As a smaller but technically focused player, CSO competes with the iTrace on specific corneal topography and wavefront functions in regional markets.

TypeBroad incumbent
Description

Heidelberg Engineering is an incumbent in ophthalmic imaging, particularly spectral-domain OCT platforms (Heidelberg Retina Tomograph) used by ophthalmologists. The company acquired Oculus and now competes broadly with Tracey across anterior and posterior segment diagnostics, with greater R&D scale and global distribution.

6Carl Zeiss Meditec
TypeBroad incumbent
Description

Carl Zeiss Meditec is a leading global ophthalmic medical technology company spanning cataract surgical devices, IOLs, OCT imaging, and refractive diagnostics. While broader than Tracey, Zeiss competes for the same ophthalmic capital budgets and increasingly bundles diagnostic platforms (e.g., IOLMaster biometry) that overlap with iTrace workflow integration.

7Marco (I·O·M)
TypeDirect peer
Description

Marco's OPD III is a 5-in-1 wavefront aberrometer/topographer/autorefractor/keratometer/pupillometer — essentially the direct head-to-head competitor to the iTrace. Tracey features an explicit "iTrace vs Marco OPD" comparison page, confirming identical clinical use cases (cataract and refractive pre-op planning, IOL selection) and target customers (ophthalmologists and optometrists).

TypeDirect peer
Description

Nidek's OPD-Scan III is a wavefront aberrometer that competes directly with the iTrace in cataract and refractive surgery workups across global ophthalmic markets. Both devices target ophthalmologists and optometrists performing objective refraction, corneal topography, and IOL power calculations using comparable technical approaches.

TypeEmerging player
Description

Ziemer specializes in femtosecond laser cataract surgery systems and diagnostic imaging devices for ophthalmology. It is smaller than the broad incumbents but competes in the premium cataract surgical workflow that the iTrace is increasingly integrated with, particularly in markets deploying femto-cataract platforms.

TypeBroad incumbent
Description

Bausch + Lomb / BVI is a major player in cataract surgical instruments and intraocular lenses (e.g., enVista, LuxSmart). While primarily a surgical/IOL company, its diagnostic partnerships and bundled offerings (e.g., with IOL biometry and surgical planning) overlap with the iTrace's pre-operative IOL selection workflow.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tracey Technologies

Ophthalmic Diagnostic Equipmenttraceytechnologies.com

Tracey Technologies is a privately held Houston-based medical device company that designs and sells the iTrace, a 5-in-1 ophthalmic diagnostic workstation using patented ray tracing technology, primarily serving cataract and refractive surgeons globally via direct sales.

What Tracey Technologies does

Tracey Technologies is a privately held US medical device company founded in 1999 and headquartered in Houston, Texas, that designs, manufactures, and sells the iTrace — a 5-in-1 ophthalmic diagnostic workstation combining wavefront aberrometry, corneal topography, autorefraction, keratometry, and pupillometry in a single device. Its core technical differentiator is a patented ray tracing wavefront sensor that projects 256 parallel light rays through the pupil entrance and measures each ray's retinal landing position, enabling the device to mathematically separate corneal from internal optical contributions to vision loss — a capability the company states competitors using Hartmann-Shack sensors cannot replicate, particularly in highly aberrated eyes or through implanted/ocular-surface-compromised lenses. Layered on this sensor are proprietary 0–10 clinical indices (Dysfunctional Lens Index, Corneal Performance Index, Quality of Vision Index, Tear Film Index) plus surgical planning modules (Toric Planner, Toric Check) that the company markets primarily to cataract and refractive surgeons for premium IOL selection, toric IOL alignment, and post-operative verification.

The company monetizes primarily through one-time hardware sales of the iTrace device on a quote-based motion, supplemented by downloadable paid software upgrades (most recently iTrace Prime v7.0 in 2023), on-site and remote training, and ongoing customer support. It serves a global installed base of ophthalmologists and optometrists across the United States, Europe, Canada, Latin America, India, the Middle East, Russia, and Southern Africa, sold through a wholly direct sales organization of regional managers rather than a distributor network. The company is founder-controlled (CEO Joe Wakil, who also founded EyeSys Technologies, the firm credited with pioneering commercial corneal topography) and has not disclosed institutional funding, M&A, or leadership transitions.

Tracey Technologies firmographics

Firmographics
Name
Tracey Technologies
Legal name
Tracey Technologies Corporation
Website
https://traceytechnologies.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
Tracey Technologies is a privately held Houston-based medical device company that designs and sells the iTrace, a 5-in-1 ophthalmic diagnostic workstation using patented ray tracing technology, primarily serving cataract and refractive surgeons globally via direct sales.
Ownership category
akta.pro rank

Tracey Technologies industry classification

Industry
Product category
Ophthalmic Diagnostic Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Ophthalmic Goods Manufacturing (339115)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAJAA
Refractive Diagnostics & Biometry (Autorefractors, Keratometers, Topography/Tomography, A-Scan/Optical Biometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAHAJAH
Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAKAKAF
Cornea, External Disease & Refractive Surgery (LASIK/PRK)

Keywords

  • Ophthalmic diagnostic equipment
  • Wavefront aberrometry devices
  • Corneal topography systems
  • Cataract surgery planning
  • Ray tracing technology

Where Tracey Technologies is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices6 records

Markets served

Tracey Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. iTrace Device Sales: Primary revenue from sale of the iTrace ophthalmic diagnostic device. The device combines wavefront aberrometry, corneal topography, autorefraction, keratometry, and pupillometry in a single piece of equipment for ophthalmic practices.
  2. Software Upgrades: Revenue from software upgrades (e.g., Version 7.0 iTrace Prime) that can be downloaded on existing hardware, providing new features and capabilities.
  3. Customer Support & Training: Ongoing support services including on-site and remote training, software activation, and technical support for existing iTrace users.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractiTrace Device - Base Configuration

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Tracey Technologies product offering

Product offering

Core offering

Tracey Technologies manufactures and sells the iTrace, a 5-in-1 ophthalmic diagnostic device that combines a wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer in a single unit. The device uses patented ray tracing technology (256 parallel light rays projected through the pupil) to objectively separate corneal from internal optical performance, and is sold with proprietary software (currently iTrace Prime / Version 7.0) that delivers diagnostic indices (DLI, CPI, QVI, TFI) and Toric Planner/Check surgical planning tools. The product is sold directly to ophthalmologists, cataract and refractive surgeons, and optometrists worldwide, supported by downloadable software upgrades and on-site or remote training.

Product overview

Tracey Technologies offers the iTrace as its core product — a unified ophthalmic diagnostic platform that combines 5 devices in 1 (wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer). The hardware platform is upgraded through software versions, with iTrace Prime (Version 7.0) being the latest. Key proprietary metrics include the Dysfunctional Lens Index (DLI), Corneal Performance Index (CPI), Quality of Vision Index (QVI), and Tear Film Index (TFI), all displayed on 0-10 scales for clinical decision-making. Surgical planning features include Toric Planner for pre-operative calculations and Toric Check for post-operative verification without dilation. The system enables separation of corneal from internal optical performance, making it unique for premium IOL selection and cataract surgery planning.

Differentiator

Problem solved

Functional benefit

Brands

  • iTrace: The flagship 5-in-1 ophthalmic device combining wavefront aberrometry, corneal topography, autorefraction, keratometry, and pupillometry using proprietary ray-tracing technology.
  • iTrace Prime

Products and services

  • iTrace Device 5-in-1 ophthalmic diagnostic device combining wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer in a single unit. Uses patented ray tracing technology to send 256 parallel light rays through the eye for objective measurement, sold to ophthalmologists, cataract and refractive surgeons, and optometrists.
  • iTrace Prime Software (Version 7.0) Latest software platform for the iTrace device featuring the Prime Dashboard, Tear Film Index, improved imaging quality, and enhanced surgical planning tools. Sold as a downloadable upgrade that adds new capabilities to existing iTrace hardware.

Quantifiable outcome

  • 40% premium IOL conversion rate achieved by Dr. Garg (up from 5% prior to iTrace adoption)
  • +4 more outcomes

Companies that use Tracey Technologies

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles1 record

Tracey Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature8 records

Tracey Technologies partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Tracey Technologies competitors and assessment

Company assessment

Broad incumbents

  • Topcon Healthcare: Topcon offers a broad portfolio of ophthalmic diagnostic instruments (refraction, OCT, corneal mapping, perimetry) used in optometry and ophthalmology practices worldwide. Topcon's multi-modality diagnostic platforms compete with iTrace for clinical budget and workflow integration, particularly in optometric referral practices.
  • Alcon: Alcon is a global leader in cataract surgical devices and premium IOLs (PanOptix, Vivity) following its acquisition of WaveLight and other diagnostic assets. As a buyer of premium IOLs, Alcon's equipment partners and bundled diagnostic solutions compete with the iTrace in the same ophthalmic surgical suite.
  • Heidelberg Engineering: Heidelberg Engineering is an incumbent in ophthalmic imaging, particularly spectral-domain OCT platforms (Heidelberg Retina Tomograph) used by ophthalmologists. The company acquired Oculus and now competes broadly with Tracey across anterior and posterior segment diagnostics, with greater R&D scale and global distribution.
  • Carl Zeiss Meditec: Carl Zeiss Meditec is a leading global ophthalmic medical technology company spanning cataract surgical devices, IOLs, OCT imaging, and refractive diagnostics. While broader than Tracey, Zeiss competes for the same ophthalmic capital budgets and increasingly bundles diagnostic platforms (e.g., IOLMaster biometry) that overlap with iTrace workflow integration.
  • Bausch + Lomb (BVI Medical): Bausch + Lomb / BVI is a major player in cataract surgical instruments and intraocular lenses (e.g., enVista, LuxSmart). While primarily a surgical/IOL company, its diagnostic partnerships and bundled offerings (e.g., with IOL biometry and surgical planning) overlap with the iTrace's pre-operative IOL selection workflow.

Direct peers

  • Oculus (Pentacam): OCULUS Pentacam is a leading corneal topography and tomography platform competing for the same diagnostic cabinet in refractive and cataract practices. Tracey markets directly against Pentacam on its website, indicating they compete for the same budget, same workflow, and same surgical planning use cases — particularly cataract/IOL and refractive surgery pre-operative assessment.
  • Marco (I·O·M): Marco's OPD III is a 5-in-1 wavefront aberrometer/topographer/autorefractor/keratometer/pupillometer — essentially the direct head-to-head competitor to the iTrace. Tracey features an explicit "iTrace vs Marco OPD" comparison page, confirming identical clinical use cases (cataract and refractive pre-op planning, IOL selection) and target customers (ophthalmologists and optometrists).
  • Nidek: Nidek's OPD-Scan III is a wavefront aberrometer that competes directly with the iTrace in cataract and refractive surgery workups across global ophthalmic markets. Both devices target ophthalmologists and optometrists performing objective refraction, corneal topography, and IOL power calculations using comparable technical approaches.

Emerging players

  • Costruzione Strumenti Oftalmici (CSO): CSO is an Italian ophthalmic equipment manufacturer specializing in corneal topography, aberrometry, and biometry devices sold to ophthalmic clinics worldwide. As a smaller but technically focused player, CSO competes with the iTrace on specific corneal topography and wavefront functions in regional markets.
  • Ziemer Ophthalmology: Ziemer specializes in femtosecond laser cataract surgery systems and diagnostic imaging devices for ophthalmology. It is smaller than the broad incumbents but competes in the premium cataract surgical workflow that the iTrace is increasingly integrated with, particularly in markets deploying femto-cataract platforms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Tracey Technologies social profiles

Digital presence

Tracey Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tracey Technologies leadership team

Management profile

Number of profiles

Profiles8 records

Tracey Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tracey Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tracey Technologies

What does Tracey Technologies do?

Tracey Technologies manufactures and sells the iTrace, a 5-in-1 ophthalmic diagnostic device that combines a wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer in a single unit. The device uses patented ray tracing technology (256 parallel light rays projected through the pupil) to objectively separate corneal from internal optical performance, and is sold with proprietary software (currently iTrace Prime / Version 7.0) that delivers diagnostic indices (DLI, CPI, QVI, TFI) and Toric Planner/Check surgical planning tools. The product is sold directly to ophthalmologists, cataract and refractive surgeons, and optometrists worldwide, supported by downloadable software upgrades and on-site or remote training.

Is Tracey Technologies a public or private company?

Tracey Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Tracey Technologies founded?

Tracey Technologies was founded in 1999. It employs 11 to 50 people.

Where is Tracey Technologies based?

Tracey Technologies is headquartered in Houston, United States, in the North America region.

How does Tracey Technologies make money?

Three revenue lines are on record. iTrace Device Sales are the primary driver. The others are software Upgrades and customer Support & Training.

Who are Tracey Technologies's main competitors?

Broad incumbents on record are Topcon Healthcare, Alcon, Heidelberg Engineering, Carl Zeiss Meditec and Bausch + Lomb (BVI Medical). Direct peers are Oculus (Pentacam), Marco (I·O·M) and Nidek. Emerging players are Costruzione Strumenti Oftalmici (CSO) and Ziemer Ophthalmology.

Does Tracey Technologies have an API?

No public API is recorded for Tracey Technologies.

What industry is Tracey Technologies in?

Tracey Technologies's product category is Ophthalmic Diagnostic Equipment. Its primary akta.pro industry code is HLAHAJAA, Refractive Diagnostics & Biometry (Autorefractors, Keratometers, Topography/Tomography, A-Scan/Optical Biometry), with a secondary code of HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals